NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 207 filers reported holding NEKTAR THERAPEUTICS in Q1 2017. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $17,960,000 | +4.7% | 1,000,000 | 0.0% | 0.58% | +37.2% |
Q2 2021 | $17,160,000 | -14.2% | 1,000,000 | 0.0% | 0.42% | -3.6% |
Q1 2021 | $20,000,000 | +198.3% | 1,000,000 | +222.0% | 0.44% | +123.9% |
Q4 2019 | $6,704,000 | -94.7% | 310,579 | -74.0% | 0.20% | -97.2% |
Q1 2018 | $126,694,000 | +15.7% | 1,192,300 | -35.0% | 7.00% | +26.8% |
Q4 2017 | $109,526,000 | +291.4% | 1,834,000 | +57.3% | 5.52% | +333.7% |
Q3 2017 | $27,986,000 | +22.8% | 1,166,100 | 0.0% | 1.27% | +4.3% |
Q2 2017 | $22,797,000 | +45.9% | 1,166,100 | +75.2% | 1.22% | +19.1% |
Q1 2017 | $15,622,000 | +58.9% | 665,600 | +16.3% | 1.02% | +18.0% |
Q3 2016 | $9,829,000 | +36.4% | 572,100 | -12.7% | 0.87% | -5.1% |
Q1 2015 | $7,205,000 | -29.0% | 655,000 | 0.0% | 0.92% | -7.9% |
Q4 2014 | $10,153,000 | – | 655,000 | – | 1.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
CM Management, LLC | 50,000 | $858,000 | 0.62% |
Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |